Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan-Kettering.
Physician-scientist Siddhartha Mukherjee, author of The Emperor of All Maladies: A Biography of Cancer, spoke to 2013 graduates of the “tenderness and tension” inherent in scientific discovery.
Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.
Memorial Sloan-Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.
Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.
Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.
